APA (7th ed.) Citation

Dieu, D. C., Pernice, H. F., Muratovic, H., Wetzel, P. J., Barzen, G., Wieder, N. W., . . . Hahn, K. (2025, September). Real-world treatment management in hereditary transthyretin amyloidosis – an experience report and proposal for therapy switch decision criteria. Neurological Research and Practice.

Chicago Style (17th ed.) Citation

Dieu, Duc Chu, et al. "Real-world Treatment Management in Hereditary Transthyretin Amyloidosis – an Experience Report and Proposal for Therapy Switch Decision Criteria." Neurological Research and Practice Sep. 2025.

MLA (9th ed.) Citation

Dieu, Duc Chu, et al. "Real-world Treatment Management in Hereditary Transthyretin Amyloidosis – an Experience Report and Proposal for Therapy Switch Decision Criteria." Neurological Research and Practice, Sep. 2025.